Efficient internalization of silica-coated iron oxide nanoparticles of different sizes by primary human macrophages and dendritic cells

Toxicology and Applied Pharmacology

Volumn 253, Issue 2, 2011, Pages 81-93

  Kunzmann, Andrea ^a   Andersson, Britta ^a   Vogt, Carmen ^b   Feliu, Neus ^a   Ye, Fei ^b   Gabrielsson, Susanne ^a   Toprak, Muhammet S ^b   Buerki Thurnherr, Tina ^c   Laurent, Sophie ^d   Vahter, Marie ^a   Krug, Harald ^c   Muhammed, Mamoun ^b   Scheynius, Annika ^a   Fadeel, Bengt ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^c Swiss Federal Laboratories of Materials Testing and Research   (Switzerland)

^d UNIVERSITY OF MONS   (Belgium)

Author keywords

Biocompatibility; Cytokine secretion; Dendritic cells; Macrophages; Superparamagnetic nanoparticles; Surface coating

Indexed keywords

CYTOKINE; DEXTRAN; IRON OXIDE; NANOPARTICLE; SILICON DIOXIDE;

ARTICLE; BIOCOMPATIBILITY; CELL VIABILITY; CYTOKINE RELEASE; CYTOSKELETON; CYTOTOXICITY; DENDRITIC CELL; INTERNALIZATION; LIGHT SCATTERING; MACROPHAGE; MAGNETISM; MATERIAL COATING; ZETA POTENTIAL;

CELL SURVIVAL; CYTOKINES; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MACROPHAGES; MAGNETICS; MAGNETITE NANOPARTICLES; MICROSCOPY, ELECTRON, TRANSMISSION; PARTICLE SIZE; SILICON DIOXIDE;

EID: 79955636194     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2011.03.011     Document Type: Article

References (67)

1. Aggarwal P., Hall J.B., McLeland C.B., Dobrovolskaia M.A., McNeil S.E. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv. Drug Deliv. Rev. 2009, 61:428-437.
2. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
3. Barrera C., Herrera A.P., Rinaldi C. Colloidal dispersions of monodisperse magnetite nanoparticles modified with poly(ethylene glycol). J. Colloid Interface Sci. 2009, 329:107-113.
4. Bierry G., Jehl F., Neuville A., Lefevre S., Robert P., Kremer S., Dietemann J.L. MRI of macrophages in infectious knee synovitis. AJR Am. J. Roentgenol. 2010, 194:W521-W526.
5. Bourrinet P., Bengele H.H., Bonnemain B., Dencausse A., Idee J.M., Jacobs P.M., Lewis J.M. Preclinical safety and pharmacokinetic profile of ferumoxtran-10, an ultrasmall superparamagnetic iron oxide magnetic resonance contrast agent. Investig. Radiol. 2006, 41:313-324.
6. Bumb A., Brechbiel M.W., Choyke P.L., Fugger L., Eggeman A., Prabhakaran D., Hutchinson J., Dobson P.J. Synthesis and characterization of ultra-small superparamagnetic iron oxide nanoparticles thinly coated with silica. Nanotechnology 2008, 19:335601.
7. Bumb A., Regino C.A., Perkins M.R., Bernardo M., Ogawa M., Fugger L., Choyke P.L., Dobson P.J., Brechbiel M.W. Preparation and characterization of a magnetic and optical dual-modality molecular probe. Nanotechnology 2010, 21:175704.
8. Cederwall T., Lynch I., Foy M., Berggard T., Donnelly S.C., Cagney G., Linse S., Dawson K.A. Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angew. Chem. Int. Ed Engl. 2007, 46:5754-5756.
9. Cory A.H., Owen T.C., Barltrop J.A., Cory J.G. Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun. 1991, 3:207-212.
10. de Vries I.J., Lesterhuis W.J., Barentsz J.O., Verdijk P., van Krieken J.H., Boerman O.C., Oyen W.J., Bonenkamp J.J., Boezeman J.B., Adema G.J., Bulte J.W., Scheenen T.W., Punt C.J., Heerschap A., Figdor C.G. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat. Biotechnol. 2005, 23:1407-1413.
11. Deng Y.-H., Wang C.-C., Hu J.-H., Yang W.-L., Fu S.-K. Investigation of formation of silica-coated magnetite nanoparticles via sol-gel approach. Colloid Surf. Physicochem. Eng Asp. 2005, 262:87-93.
12. Deng Z.J., Liang M., Monteiro M., Toth I., Minchin R.F. Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. Nat. Nanotechnol. 2011, 6:39-44.
13. Dobrovolskaia M.A., McNeil S.E. Immunological properties of engineered nanomaterials. Nat. Nanotechnol. 2007, 2:469-478.
14. Dutz S., Andrä W., Hergt R., Müller R., Oestreich C., Schmidt C., Töpfer J., Zeisberger M., Bellemann M.E. Influence of dextran coating on the magnetic behaviour of iron oxide nanoparticles. J. Magn. Magn. Mater. 2007, 311:51-54.
15. Fleige G., Seeberger F., Laux D., Kresse M., Taupitz M., Pilgrimm H., Zimmer C. In vitro characterization of two different ultrasmall iron oxide particles for magnetic resonance cell tracking. Investig. Radiol. 2002, 37:482-488.
16. Flogel U., Ding Z., Hardung H., Jander S., Reichmann G., Jacoby C., Schubert R., Schrader J. In vivo monitoring of inflammation after cardiac and cerebral ischemia by fluorine magnetic resonance imaging. Circulation 2008, 118:140-148.
17. Geraldes C., Laurent S. Classification and basic properties of contrast agents for magnetic resonance imaging. Contrast Media Mol. Imaging 2009, 4:1-23.
18. Gordon S., Taylor P.R. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 2005, 5:953-964.
19. Hamm B., Staks T., Taupitz M., Maibauer R., Speidel A., Huppertz A., Frenzel T., Lawaczeck R., Wolf K.J., Lange L. Contrast-enhanced MR imaging of liver and spleen: first experience in humans with a new superparamagnetic iron oxide. J. Magn. Reson. Imaging 1994, 4:659-668.
20. Im S.H., Herricks T., Lee Y.T., Xia Y. Synthesis and characterization of monodisperse silica colloids loaded with superparamagnetic iron oxide nanoparticles. Chem. Phys. Lett. 2005, 401:19-23.
21. Josephson L., Lewis J., Jacobs P., Hahn P.F., Stark D.D. The effects of iron oxides on proton relaxivity. Magn. Reson. Imaging 1988, 6:647-653.
22. Kippler M., Goessler W., Nermell B., Ekstrom E.C., Lonnerdal B., El Arifeen S., Vahter M. Factors influencing intestinal cadmium uptake in pregnant Bangladeshi women-a prospective cohort study. Environ. Res. 2009, 109:914-921.
23. Kippler M., Lonnerdal B., Goessler W., Ekstrom E.C., Arifeen S.E., Vahter M. Cadmium interacts with the transport of essential micronutrients in the mammary gland - a study in rural Bangladeshi women. Toxicology 2009, 257:64-69.
24. Kobukai S., Baheza R., Cobb J.G., Virostko J., Xie J., Gillman A., Koktysh D., Kerns D., Does M., Gore J.C., Pham W. Magnetic nanoparticles for imaging dendritic cells. Magn. Reson. Med. 2010, 63:1383-1390.
25. Koenig S.H., Kellar K.E., Fujii D.K., Gunther W.H.H., Briley-Saebo K., Spiller M. Three types of physical measurements needed to characterize iron oxide nanoparticles for MRI and MRA: magnetization, relaxometry, and light scattering. Acad. Radiol. 2002, 9:S5-S10.
26. Kunzmann A., Andersson B., Thurnherr T., Krug H., Scheynius A., Fadeel B. Toxicology of engineered nanomaterials: focus on biocompatibility, biodistribution and biodegradation. Biochim. Biophys. Acta 2011, 1810:361-373.
27. Laurent S., Boutry S., Mahieu I., Vander Elst L., Muller R.N. Iron oxide based MR contrast agents: from chemistry to cell labeling. Curr. Med. Chem. 2009, 16:4712-4727.
28. Lin W., Huang Y.W., Zhou X.D., Ma Y. In vitro toxicity of silica nanoparticles in human lung cancer cells. Toxicol. Appl. Pharmacol. 2006, 217:252-259.
29. Liong M., Lu J., Kovochich M., Xia T., Ruehm S.G., Nel A.E., Tamanoi F., Zink J.I. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano 2008, 2:889-896.
30. Lu Y., Yin Y., Mayers B.T., Xia Y. Modifying the surface properties of superparamagnetic iron oxide nanoparticles through a sol-gel approach. Nano Lett. 2002, 2:183-186.
31. Lu C.-W., Hung Y., Hsiao J.-K., Yao M., Chung T.-H., Lin Y.-S., Wu S.-H., Hsu S.-C., Liu H.-M., Mou C.-Y., Yang C.-S., Huang D.-M., Chen Y.-C. Bifunctional magnetic silica nanoparticles for highly efficient human stem cell labelling. Nano Lett. 2007, 7:149-154.
32. Lundqvist M., Stigler J., Elia G., Lynch I., Cedervall T., Dawson K.A. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc. Natl Acad. Sci. U. S. A. 2008, 105:14265-14270.
33. Mahmoudi M., Sahraian M.A., Shokrgozar M.A., Laurent S. Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of multiple sclerosis. ACS Chem. Neurosci 2011, 2:118-140.
34. Metz S., Bonaterra G., Rudelius M., Settles M., Rummeny E.J., Daldrup-Link H.E. Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro. Eur. Radiol. 2004, 14:1851-1858.
35. Mornet S., Vasseur S., Grasset F., Duguet E. Magnetic nanoparticle design for medical diagnosis and therapy. J. Mater. Chem. 2004, 14:2161-2175.
36. Narita A., Nakab K., Chujo Y. Facile control of silica shell layer thickness on hydrophilic iron oxide nanoparticles via reverse micelle method. Colloid Surf. Physicochem. Eng. Asp. 2009, 336:46-56.
37. Oghabian M.A., Gharehaghaji N., Amirmohseni S., Khoei S., Guiti M. Detection sensitivity of lymph nodes of various sizes using USPIO nanoparticles in magnetic resonance imaging. Nanomedicine 2010, 6:496-499.
38. Patel D., Kell A., Simard B., Deng J., Xiang B., Lin H.Y., Gruwel M., Tian G. Cu(2+)-labeled, SPION loaded porous silica nanoparticles for cell labeling and multifunctional imaging probes. Biomaterials 2010, 31:2866-2873.
39. Qin J., Laurent S., Jo Y.S., Roch A., Mikhaylova M., Bhujwalla Z.M., Muller R.N., Muhammed M. A high-performance magnetic resonance imaging T-2 contrast agent. Adv. Mater. 2007, 19:1874-1878.
40. Rao K.S., El-Hami K., Kodaki T., Matsushige K., Makino K. A novel method for synthesis of silica nanoparticles. J. Colloid Interface Sci. 2005, 289:125-131.
41. Raynal I., Prigent P., Peyramaure S., Najid A., Rebuzzi C., Corot C. Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10. Investig. Radiol. 2004, 39:56-63.
42. Reimer P., Balzer T. Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications. Eur. Radiol. 2003, 13:1266-1276.
43. Reynolds E.S. The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J. Cell Biol. 1963, 17:208-212.
44. Riegler J., Wells J.A., Kyrtatos P.G., Price A.N., Pankhurst Q.A., Lythgoe M.F. Targeted magnetic delivery and tracking of cells using a magnetic resonance imaging system. Biomaterials 2010, 31:5366-5371.
45. Riehemann K., Schneider S.W., Luger T.A., Godin B., Ferrari M., Fuchs H. Nanomedicine-challenge and perspectives. Angew. Chem. Int. Ed Engl. 2009, 48:872-897.
46. Roch A., Gossuin Y., Muller R.N., Gillis P. Superparamagnetic colloid suspensions: water magnetic relaxation and clustering. J. Magn. Magn. Mater. 2005, 293:532-539.
47. Salgueiriño-Maceira V., Correa-Duarte M.A. Increasing the complexity of magnetic core/shell structured nanocomposites for biological applications. Adv. Mater. 2007, 19:4131-4144.
48. Santra S., Tapec R., Theodoropoulou N., Dobson J., Hebard A., Tan W. Synthesis and characterization of silica-coated iron oxide nanoparticles in microemulsion: the effect of nonionic surfactants. Langmuir 2001, 17:2900-2906.
49. Shvedova A.A., Kagan V.E., Fadeel B. Close encounters of the small kind: adverse effects of man-made materials interfacing with the nano-cosmos of biological systems. Annu. Rev. Pharmacol. Toxicol. 2010, 50:63-88.
50. Stromberg M., Gunnarsson K., Valizadeh S., Svedlindh P., Stromme M. Aging phenomena in ferrofluids suitable for magnetic biosensor applications. J. Appl. Phys. 2007, 101.
51. Stöber W., Fink A., Bohn E. Controlled growth of monodisperse silica spheres in the micron size range. J. Colloid Interface Sci. 1968, 26:62-69.
52. Truijers M., Fütterer J.J., Takahashi S., Heesakkers R.A., Blankensteijn J.D., Barentsz J.O. In vivo imaging of the aneurysm wall with MRI and a macrophage-specific contrast agent. AJR Am. J. Roentgenol. 2009, 193:W437-W441.
53. Valable S., Barbier E.L., Bernaudin M., Roussel S., Segebarth C., Petit E., Remy C. In vivo MRI tracking of exogenous monocytes/macrophages targeting brain tumors in a rat model of glioma. Neuroimage 2008, 40:973-983.
54. Vallhov H., Qin J., Johansson S.M., Ahlborg N., Muhammed M.A., Scheynius A., Gabrielsson S. The importance of an endotoxin-free environment during the production of nanoparticles used in medical applications. Nano Lett. 2006, 6:1682-1686.
55. Vallhov H., Gabrielsson S., Stromme M., Scheynius A., Garcia-Bennett A.E. Mesoporous silica particles induce size dependent effects on human dendritic cells. Nano Lett. 2007, 7:3576-3582.
56. Veiseh O., Gunn J.W., Zhang M. Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv. Drug Deliv. Rev. 2009, 62:284-304.
57. Vigor K.L., Kyrtatos P.G., Minogue S., Al-Jamal K.T., Kogelberg H., Tolner B., Kostarelos K., Begent R.H., Pankhurst Q.A., Lythgoe M.F., Chester K.A. Nanoparticles functionalized with recombinant single chain Fv antibody fragments (scFv) for the magnetic resonance imaging of cancer cells. Biomaterials 2010, 31:1307-1315.
58. Walczyk D., Bombelli F.B., Monopoli M.P., Lynch I., Dawson K.A. What the cell "sees" in bionanoscience. J. Am. Chem. Soc. 2010, 132:5761-5768.
59. Weissleder R., Stark D.D., Engelstad B.L., Bacon B.R., Compton C.C., White D.L., Jacobs P., Lewis J. Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR Am. J. Roentgenol. 1989, 152:167-173.
60. Witasp E., Kupferschmidt N., Bengtsson L., Hultenby K., Smedman C., Paulie S., Garcia-Bennett A.E., Fadeel B. Efficient internalization of mesoporous silica particles of different sizes by primary human macrophages without impairment of macrophage clearance of apoptotic or antibody-opsonized target cells. Toxicol. Appl. Pharmacol. 2009, 239:306-319.
61. Witasp E., Shvedova A.A., Kagan V.E., Fadeel B. Single-walled carbon nanotubes impair human macrophage engulfment of apoptotic cell corpses. Inhal. Toxicol. 2009, 21:131-136.
62. Wodnicka M., Pierzchalska M., Bereiter-Hahn J., Kajstura J. Comparative study on effects of cytochalasins B and D on F-actin content in different cell lines and different culture conditions. Folia Histochem. Cytobiol. 1992, 30:107-111.
63. Vogt C., Laurent S., Bridot J.-L., Muller R., Toprak M.S., Muhammed M. High quality and tuneable silica shell-magnetic core nanoparticles. J. Nanopart. Res. 2010, 12:1137-1147.
64. Yi D.K., Lee S.S., Papaefthymiou G.C., Ying J.Y. Nanoparticle architectures templated by SiO2/Fe2O3 nanocomposites. Chem. Mater. 2006, 18:614-619.
65. Yi D.K., Selvan S.T., Lee S.S., Papaefthymiou G.C., Kundaliya D., Ying J.Y. Silica-coated nanocomposites of magnetic nanoparticles and quantum dots. J. Am. Chem. Soc. 2005, 127:4990-4991.
66. Zelivyanskaya M.L., Nelson J.A., Poluektova L., Uberti M., Mellon M., Gendelman H.E., Boska M.D. Tracking superparamagnetic iron oxide labeled monocytes in brain by high-field magnetic resonance imaging. J. Neurosci. Res. 2003, 73:284-295.
67. Zhang M., Cushing B.L., O'Connor C.J. Synthesis and characterization of monodisperse ultra-thin silica-coated magnetic nanoparticles. Nanotechnology 2008, 19. 085601/085601-085601/085605.